Home/Organogenesis/Patrick Bilbo

PB

Patrick Bilbo

Chief Operating Officer

Therapeutic Areas

Advanced Wound Care Surgery Sports Medicine

Organogenesis Pipeline

Drug	Indication	Phase
Apligraf®	Diabetic Foot Ulcers, Venous Leg Ulcers	Approved
Dermagraft®	Diabetic Foot Ulcers	Approved
PuraPly®	Various Wounds (surgical, traumatic, chronic)	Approved
PuraPly® AM	Various Wounds with antimicrobial management	Approved

Leadership Team at Organogenesis

Gary S. Gillheeney, Sr.

President, Chief Executive Officer and Chair of the Board

David C. Francisco

Chief Financial Officer

Chief Commercial Officer

View full Organogenesis profile